A great Dopp kit will keep your grooming essentials organized once you reach your destination and prevent them from leaking in your bag while you’re in transit. It must be waterproof (or at ...
An indoor-gardening kit is a relatively new entry in the home-appliance canon, which always makes me wonder if a product is here to stay or if it’s going to become obsolete. But after using an ...
Pfizer Inc. announced positive results from the phase 3 BREAKWATER trial evaluating Braftovi (encorafenib) in combination with cetuximab (marketed as Erbitux) and mFOLFOX6 (fluorouracil, leucovorin, ...
Of patients on Braftovi plus cetuximab and mFOLFOX6, 22.4% (n=15) had a response lasting 12 months or longer, compared to 11.4% (n=5) with chemotherapy with or without bevacizumab.
— Recommendations are independently chosen by our editors. Purchases you make through our links may earn us and our publishing partners a commission. Super Bowl 2025 is on Sunday, February 9 ...
The estimated median duration of response was 13.9 months with Braftovi plus cetuximab and mFOLFOX6 and 11.1 months with chemotherapy with or without bevacizumab. Of patients on Braftovi plus ...
On Saturday, Pfizer Inc. (NYSE:PFE) revealed results from the Phase 3 BREAKWATER trial evaluating Braftovi (encorafenib) in combination with cetuximab (marketed as Erbitux) and mFOLFOX6 (fluorouracil, ...
NEW YORK, NY, USA I January 25, 2025 I Pfizer Inc. (NYSE: PFE) today announced positive results from the Phase 3 BREAKWATER trial evaluating BRAFTOVI ® (encorafenib) in combination with cetuximab ...
First-line treatment with targeted therapies plus chemotherapy offered overall response benefits in BRAF V600E-mutant metastatic colorectal cancer (mCRC), according to the BREAKWATER trial. The study ...
From left to right: The 2025 home shirts of Super League clubs Hull KR, Leeds Rhinos, Hull FC and Castleford Tigers - Image Credits: Hull KR, Hull FC, OXEN Sports It’s that time of the year again when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results